Melanoma symptoms provide key warning signs that can help you find this disease early, when it is most treatable. Learn ...

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

Er-Kim will distribute KIMMTRAK® (tebentafusp) for the treatment of HLA-A*02:01-positive adults with unresectable or ...

Emergency department (ED) presentations are associated with higher cancer mortality. This study aimed to investigate the ...

Like other cancers, melanoma is rising among young adults. It's now the 2nd most common cancer in 15 to 39 year-olds.

While artificial intelligence (AI) holds promise to improve the diagnosis of melanoma, researchers of a new review outlined ...

A high-fiber diet may improve response rates and event-free survival outcomes in patients with advanced melanoma receiving standard immunotherapy.

According to the latest study from BCC Research, "Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic ...

During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the 10 best healthcare penny stocks to buy according to analysts.

Fran Ireland, 45, from Ramsbottom, was on a trip to Turkey in 2022 when her partner and two daughters noticed an unusual mole on her upper body ...

A new study led by researchers at Lund University in Sweden, reveals that melanoma, the deadliest form of skin cancer, can in some cases be driven by ...